Tuesday, May 28, 2019 10:26:11 PM
Yep. Only going higher. Optho solutions from IMMY division growing market share plus all value from multiple offshoot companies.
Strong Buy
Strong Buy
Recent HROW News
- Form 8-K - Current report • Edgar (US Regulatory) • 03/27/2026 08:05:13 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/24/2026 08:58:32 PM
- Harrow Announces Pricing of $50.0 Million Offering of Senior Unsecured Notes Due 2030 • GlobeNewswire Inc. • 03/24/2026 08:57:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/24/2026 12:16:17 PM
- Harrow Announces Add-On Offering of $50.0 Million of Senior Unsecured Notes to Support Growth • GlobeNewswire Inc. • 03/24/2026 12:15:00 PM
- Harrow Announces Three Abstracts Accepted for Presentation at ASCRS 2026 Annual Meeting • GlobeNewswire Inc. • 03/18/2026 11:00:00 AM
- Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 03/11/2026 06:50:55 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/10/2026 12:26:19 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2026 09:05:14 PM
- Harrow to Present at Leerink Partner’s 2026 Global Healthcare Conference • GlobeNewswire Inc. • 03/04/2026 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/03/2026 09:05:17 PM
- Harrow Wins FDA Clearance to Launch Phase 3 Trial Aimed at Expanding TRIESENCE Label in Cataract Surgery • IH Market News • 03/03/2026 03:39:49 PM
- Harrow to Initiate Phase 3 Clinical Trial Seeking to Expand TRIESENCE® Label to Include Ocular Inflammation and Pain Following Cataract Surgery Indication • GlobeNewswire Inc. • 03/03/2026 12:00:00 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/02/2026 09:31:33 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/02/2026 09:15:59 PM
- Harrow Announces Q4 and Full-Year 2025 Financial Results and 2026 Financial Guidance • GlobeNewswire Inc. • 03/02/2026 09:05:00 PM
- Harrow To Report Fourth Quarter and Year-End 2025 Financial Results After Market Close on March 2, 2026 • GlobeNewswire Inc. • 02/18/2026 12:00:00 PM
- Harrow Announces Cash-Pay Direct-to-Prescriber PharmaPack™ Kits • GlobeNewswire Inc. • 02/17/2026 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/02/2026 01:21:48 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/02/2026 12:30:56 PM
- Harrow Reaffirms 2025 Full-Year Revenue Guidance of $270–$280 Million, Marking Another Year of Strong Growth • GlobeNewswire Inc. • 02/02/2026 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/08/2026 09:05:20 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/17/2025 01:50:10 AM
- Harrow to Present at Two Investor Conferences in December • GlobeNewswire Inc. • 11/24/2025 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/18/2025 01:00:40 PM
